US measles cases hit 35-year high as vaccination rates fall and public memory fades

By mid-July 2026, the United States had recorded 2,321 measles cases—more than the entire total from 2025. The virus, once nearly eradicated from American life, is spreading again, and epidemiologists are watching with alarm. William Moss, an epidemiologist at Johns Hopkins, expects the country to lose the measles-elimination status it has held since 2000. What makes this moment significant is not just the rising numbers, but what they signal: the virus is no longer confined to cases imported from abroad. It is now moving from one under-vaccinated community to another within the country itself, finding pockets of susceptible people and exploiting them.

Measles is the most contagious virus known to humans. Nine out of every ten people without immunity who encounter it will become infected. The virus travels through the air in droplets released when someone breathes, talks, or coughs—particles so small they can linger in a room for hours after the infected person has left. What makes this particularly dangerous is timing: people shed the virus for days before the characteristic rash appears, meaning they can infect others while feeling well enough to move through the world. Paul Offit, director of the Vaccine Education Center at Children's Hospital Philadelphia, puts it plainly: you need only to share someone's airspace within two hours of their presence to catch it.

The complications of measles extend far beyond the fever and spots most people remember. About one in five infected people in the United States require hospitalization. One in twenty infected children develops pneumonia. One in a thousand develops encephalitis, a brain inflammation that can cause permanent neurological damage. Between one and three of every thousand infected children die from respiratory or neurological failure. Offit described watching two healthy children—one six years old, one eight—die from measles pneumonia in the past year. "It's like dying of suffocation," he said. "It's a terrible way to die."

But the danger does not end with recovery. Measles can suppress the immune system for years afterward, erasing protection the body had built against other infections. There is also a rare but fatal complication called subacute sclerosing panencephalitis, a degenerative brain disease that can emerge up to a decade after the original infection. Children recover from measles, return to normal life, and then years later their handwriting deteriorates, their personality changes, and they descend into a vegetative state before death.

The paradox at the heart of this crisis is that vaccination's success has created the conditions for its failure. Because measles nearly disappeared from everyday American life, an entire generation has grown up without witnessing its severity. Parents have no memory of children hospitalized with pneumonia or brain inflammation. The disease became abstract, theoretical—something that happened in other places or other times. Katelyn Jetelina, an epidemiologist who writes about public health, describes this as "general amnesia about these diseases." She points to misinformation on social media, eroding trust in institutions, and the simple fact that when a disease vanishes, so does the collective understanding of why it was dangerous in the first place.

Moss notes that the most serious complications of measles are rare enough that they only become visible when case numbers climb high enough. "Unfortunately," he said, "the increasing number of measles cases in the US will once again teach us that this is not always a harmless childhood infection." The lesson, it seems, will come through experience rather than memory. Across the country, unvaccinated communities remain vulnerable. All it takes, Jetelina warns, is a spark—one case in the right place—and the disease will spread like wildfire through those pockets of susceptibility.